baber/WOPTO huggingface dataset:
Patent PT-2276258-E (PT)
Title: Decoding a block of quantized transform coefficients, wherein an even parity of the sum of the inversely quantized transform coefficients is set to an odd parity
Inventor: SUZUKI TERUHIKO
IPC: H04N19/625
Filed: 1994-03-01
Abstract: Mismatch error occur in the local decoder of a MPEG-standard compressor for a motion picture signal, and in an MPEG-standard expander for a compressed motion picture signal. This is because of the lack of a standard for rounding results of *.5 (* is an integer) obtained when a set of transform coefficients resulting from compressing the motion picture signal is inversely orthogonally transformed. The invention prevents mismatch errors by preprocessing the set of transform coefficients prior to the inverse orthogonal transform. The transform coefficients in the set are summed, and the parity (odd or even) of the sum is judged. When the parity of the sum is judged to be even, the parity of one of the transform coefficients in the set is inverted to provide a parity-inverted transform coefficient. This makes the parity of the sum odd. Then, when the set of transform coefficients including the parity-inverted transform coefficient is inversely orthogonally transformed, none of the results of the orthogonal transform will have a value of *.5.
Patent PT-538822-E (PT)
Inventor: TURNER RAYMOND L
IPC: B23K35/363
Filed: 1992-10-21
Abstract: A non-toxic, non-corrosive foaming soldering flux (14) comprises citric acid and water, together with at least one foaming agent. The foam is fast-breaking, dissipating almost immediately. Such a fast-breaking foam is novel in an aqueous-based flux. The unique flux of the invention produces solder joints of high metallic luster and excellent quality. Disposal presents no health hazards, and clean-up of flux residues is accomplished using only water and, optionally, a surfactant. <IMAGE>
Patent PT-861084-E (PT)
Inventor: MASKIEWICZ RICHARD
IPC: A61K47/42
Filed: 1996-10-29
Abstract: An improved diluent for the preparation of cisplatin suspensions from a lyophilized powder is provided. The diluent contains a pharmaceutically acceptable nonionic surfactant, which improves the accuracy and homogeneity of the therapeutic formulation. The suspension may be used directly, or may be used in preparing gel formulations for direct injection into a neoplastic lesion or surrounding tissue.
Patent PT-923566-E (PT)
Inventor: GREENWALD RICHARD B
IPC: A61K47/48
Filed: 1997-08-20
Abstract: The present invention is directed compositions of the formula:    <IMAGE>  (I)  wherein: D is a biologically active moiety; X is an electron withdrawing group; Y and Y' are independently O or S; R1 is selected from the group consisting of H, C1-6 alkyls, aryls, substituted aryls, aralkyls, heteroalkyls, substituted heteroalkyls and substituted C1-6 alkyls; (n) is an integer from 1 to about 12; and R2 is a polyalkylene oxide. In preferred embodiments, the prodrugs contain a polyethylene glycol having a molecular weight of at least about 20,000.
Patent PT-989957-E (PT)
Inventor: RUSHMERE JOHN DEREK
IPC: A61Q15/00
Filed: 1998-06-12
Abstract: An improved method and apparatus for preparing low-concentration polyaluminosilicate microgels from a water soluble silicate and an alkali metal aluminate in which the silicate and the aluminate are mixed at a rate to produce a Reynolds number of at least 4000, the mixture is aged and then diluted to a silica concentration of not more than 1.0 wt. %. The method achieves reduced silica deposition during the preparation of the microgels.
Patent PT-1029863-E (PT)
Inventor: YAEGASHI TAKASHI
IPC: A61K31/47
Filed: 1998-11-06
Abstract: The present invention relates to new camptothecin derivatives shown by the below formula, which are water-soluble and excellent in an anti-tumor activity, and to salts thereof. <CHEM>     In the formula, R<1> represents a hydrogen atom or an alkyl group with 1-6 carbon atoms, R<2> represents identically or differently 0-4 alkyl groups with 1-6 carbon atoms, a halogen atom, an alkoxyl or hydroxyl group, R<3> represents a lower alkylamino, di-lower alkylamino, arylamino, cyclicamino or lower alkoxyl group, and salts thereof.
Patent PT-1054671-E (PT)
Inventor: ISACSSON GORAN
IPC: A61P21/00
Filed: 1999-01-11
Abstract: The present invention is directed to the intramuscular use of ropivacaine for the manufacture of a medicament for use in the treatment of muskuloskeletal pain, in particular myofascial pain and tendinitis.
Patent PT-1056415-E (PT)
Inventor: ZHOU STEPHEN Q
IPC: G02B1/04
Filed: 1999-02-12
Abstract: Reduced trauma medical implants and methods for their use are disclosed wherein at least a portion of the implant is formed of a stretch-crystallizable elastomeric material formulated to exhibit the property of stretch crystallization upon substantial elongation of the implant to form stable, small-incision implant configurations having at least one dimension substantially reduced for insertion through a surgical incision that is small relative to the incision size necessary to implant the unstretched implant. Exemplary embodiments include intraocular implants formed of optically clear, high refractive index stretch-crystallizable silicone elastomers formulated to stretch crystallize at near ambient temperatures upon elongations greater than or equal to 300% and to recover their original configuration immediately upon exposure to body temperature following implantation.
Patent PT-1093517-E (PT)
Title: Neisseria meningitidis antigens and compositions
Inventor: MASIGNANI VEGA
IPC: C12N15/31
Filed: 1999-04-30
Abstract: The invention provides proteins from Neisseria meningitidis, including the amino acid sequences and the corresponding nucleotide sequences. The proteins are predicted to be useful antigens for vaccines and/or diagnostics.
Patent SG-68886-G (SG)
Title: Improvements in and relating to interesterification of triglycerides of fatty acids
IPC: C12P7/64
Filed: 1986-08-20
Abstract: In a continuous interesterification process a fatty acid ester reactant, preferably a glyceride and optionally including free fatty acid, is contacted with an enzyme as interesterification catalyst which is preferably 1,3-selective and precipitated on an inert particulate support. The catalyst is packed in a fixed bed with contact times less than 2 hours which are sufficient to effect interesterification. The process is useful for producing POSt- and StOSt-rich fats suitable for use as cocoabutter substitute fats.
Patent IE-800091-L (IE)
Title: Liposomic suspensions
IPC: A61K47/00
Filed: 1980-01-16
Abstract: Pharmaceutical suspensions of liposomes containing a drug (e.g. doxorubicin hydrochloride, aminosidine sulphate or 5- fluorouracil) are prepared by dissolution of lipidic components in a solvent, addition of an aqueous solution of the drug, and emulsification by insufflation of an inert gas until the solvent is completely removed by evaporation, and then the liposomes are separated from non-entrapped drug by shaking the suspension with a polymeric ion exchange resin or a polymeric absorbent resin to absorb the non- entrapped drug, then filtering off the resin. The ion exchange resin may be a strong or weak, anionic or cationic resin. The resultant liposomic suspensions may be lyophilised.
[GB2041871A]
Patent IE-800135-L (IE)
Title: Rifamycins
IPC: C12P17/18
Filed: 1980-01-24
Abstract: New antibiotically active compounds having the basic structure of rifamycin S, namely 3-hydroxyrifamycin S (formula A: X=>C=O; R1=OH; R2=H), 3,31-dihydroxyrifamycin S (formula A: X=>C=O; R1=R2=OH) and 1-desoxy-1-oxarifamycin S (formula A: X=-O-; R1=R2=H) <IMAGE> (A) are formed by cultivating, under aerobic conditions, a strain of Nocardia mediterranei which is derived from Streptomyces mediterranei ATCC 13 685 as the parent strain and is characterized by the ability to produce at least one of the mentioned compounds. The recombinant strain Nocardia mediterranei DSM 1415 has proved suitable. The mentioned rifamycin S analogues have analogous antibiotic properties to this but have a wider range of action, especially against gram-negative bacteria.
[US4298692A]
Patent IE-860287-L (IE)
Title: Quinolines
IPC: A61P29/00
Filed: 1986-02-03
Abstract: This invention relates to novel lipoxygenase inhibitors possessing anti-inflammatory and anti-allergic activities. The present new compounds are di- and tetra-hydroquinoline or di- and tetra-hydronapthalene derivatives, more particularly, 1,2-, 1,4-, 5,6-, or 7,8-dihydro; 1,2,3,4-tetrahydro-; 5,8-dihydro-; or 5,6,7,8-tetrahydroquinoline or napthalene derivatives of a compound of the formula: <IMAGE> and oxides, quaternary ammonium salts and acid salts thereof; wherein A is CH or N; Z is an alkylene chain containing up to 10 carbon atoms in the principal chain and a total of up to 12 carbon atoms and the said alkylene chain may be attached to the phenyl group through an oxygen atom; R is the substituent OR6 attached to one of the carbon atoms of Z in which R6 is H, lower alkyl or phenyl; X is -O(CHR5)m-, alkylene of up to 2 carbon atoms in the principal chain and up to a total of 4 carbon atoms or <IMAGE> wherein R5 is H or CH3; R1, R2, R3 and R4 are each H or OH; n'=1 or 2; and m=1 or 2.
[US4625034A]
Patent IE-37419-L (IE)
Title: Oxazolidines.
IPC: C07D263/04
Filed: 1973-03-16
Abstract: 1386751 5-(4-amino-3,5-dichloro-phenyl)- oxazolidines DR KARL THOMAE GmbH 16 March 1973 [18 March 1972] 12841/73 Heading C2C Novel compounds I in which R is hydrogen, alkyl, alkenyl optionally substituted by aryl or an aryl or heteroaryl group each optionally substituted by halogen and their acid addition salts are prepared by reaction of an amino-alcohol II with an aldehyde R-CHO, preferably under dehydrating conditions. Compounds prepared are those in which R is hydrogen, methyl, ethyl, i- or n-propyl, n-pentyl, 4-pyridyl, 2-chlorophenyl or styryl. Compounds I exhibit a broncholytic action and form with a carrier or diluent a pharmaceutical composition which may be administered orally, parenterally or rectally and which may contain other active ingredients.
[GB1386751A]
Patent IE-37153-L (IE)
Title: 3-aryl-2-halothiopropionic acids
IPC: A01N37/48
Filed: 1972-05-05
Abstract: 1344957 3 - Aryl - 2 - halopropionic acid derivatives BAYER AG 5 May 1972 [6 May 1971 2 Dec 1971] 21034/72 Heading C2C The invention comprises compounds of the general formula in which X is chlorine or bromine, R<SP>1</SP> is hydrogen, a salt-forming cation or an alkyl, alkenyl, alkynyl or cycloalkyl radical, which radical may optionally carry one or more substituents selected from halogen, haloalkyl, hydroxy, alkoxy, alkoxycarbonyl and aryl, R<SP>2</SP> is hydrogen, halogen or alkyl, R<SP>3</SP> is hydrogen or alkyl, n is 0, 1, 2 or 3 and R<SP>4</SP> is halogen, haloalkyl or nitro, the radicals R<SP>4</SP> being identical or different when n is 2 or 3. Such compounds are prepared by reacting a compound of the general formula with a compound of the general formula HS-R<SP>1</SP> where the R's, X's and n have the meanings given above. Examples are furnished. The products may be used as selective herbicides alone or in formulations with the conventional ingredients. 3 - (2,6 - Dichlorophenyl) - 2- chloropropionyl chloride is prepared by reacting the corresponding acid with thionyl chloride. 2 - Chloro - 3 - (4<SP>1 </SP>- chlorophenyl) - propionyl chloride is prepared by reacting 1,1-dichloro-3- (4<SP>1</SP> - chlorophenyl) - propene with formic acid containing some water and chlorine.
[GB1344957A]
Patent IE-39190-L (IE)
Title: Colouring glass bodies
IPC: C03C4/02
Filed: 1974-03-27
Abstract: In the coloring of bodies of glass by diffusion of coloring ions from a treatment medium into surface layers thereof, the repeatability of the resulting coloration is improved by controlling not only the treatment temperature and composition of the medium and the treatment time, but also by controlling the electrical potential within the medium between a pair of electrodes in contact therewith. Preferably, for electrodes of specified composition and structure, this potential is maintained at a value between -600 mV and +300 mV.
[US3905791A]
Patent IE-890719-L (IE)
Title: Modified proteins
IPC: C12P21/00
Filed: 1989-03-06
Abstract: Eglin mutants which differ from natural eglins B and C in that one, two or three amino acids in the region of the active centre (amino acids 45 and 46, Leu-Asp) have been replaced by other amino acids are provided. The mutants, which can be prepared by recombinant gene techniques, have valuable pharmacological properties.
Patent FI-812923-L (FI)
Inventor: ZALISZ RENE
IPC: A61P37/04
Filed: 1981-09-18
Abstract: Novel water-soluble, immunostimulating glycoproteins extracted from Klebsiella pneumoniae containing 30 to 45% by weight of proteins, 30 to 40% by weight of neutral saccharides, up to 4% by weight of glucuronic acid, 2 to 5% by weight of osamines and having a molecular weight of about 350,000 daltons.
Patent FI-851470-L (FI)
Inventor: NIJENHUIS DERK SR
IPC: B65G/
Filed: 1985-04-12
Abstract: Apparatus having vertically and horizontally movable gripping means for gripping an interchangeable container and bringing it from a lower level onto a supporting surface on a vehicle or other support, and for removing it therefrom, said gripping means comprising at least two parts (20, 28) spaced apart horizontally and/or vertically, each of them being adapted to grip, independently of the other, containers having gripping means which, relative to one another, are differently shaped or differently situated and which cooperate with the first-mentioned gripping means.
Patent FI-852759-L (FI)
Inventor: YADLOWSKY SLAWKO
IPC: B65D81/34
Filed: 1985-07-12
Abstract: An aqueous food extract of improved quality is produced by treating an infusion bag material with a water-soluble, fluoro-chemical sizing agent to prevent sorption of flavor oils by the infusion bag material, and thus enable extraction of the flavor oils into the brew during brew preparation. The infusion bag material may be treated with the sizing agent in various ways as, for example, by addition of the sizing agent during production of the infusion bag material or application of the sizing agent to the surface of the infusion bag material either before or after a food product is enclosed therein.
Patent IE-43688-L (IE)
Title: Pesticidal composition
IPC: A01N25/04
Filed: 1976-05-14
Abstract: The liquid formulation of N,N'-bis-(1-formamido-2,2,2-trichloroethyl)piperazine contains, as emulsifier, a salt of alkylbenzenesulphonic acid. The cation of the salt is Ca<2+>, Li<+>, tert.-C4H9-NH3<+> or an ammonium ion which is derived from a secondary or tertiary aliphatic amine and meets at least one of the criteria a) pKA>10.5; b) branched alkyl chain having 3 to 4 carbon atoms; c) no additional functional groups in the alkyl radicals. The liquid formulation has a fungitoxic and acaricidal activity.
[GB1518562A]
Patent IE-39790-L (IE)
Title: Coating articles
IPC: B05B15/04
Filed: 1974-05-31
Abstract: A coating system for efficient electrical precipitation of powder to articles. Articles are conveyed through a coating chamber where they are coated with a powder. Electrogasdynamic guns direct a cloud of charged particles into the coating chamber. Dilution air moves the cloud through the chamber with the articles. As the cloud moves with the articles, the charged particles precipitate to the articles. An exhaust section draws off the dilution air as the coated articles leave the chamber. Electrically conductive articles may be grounded through the conveyor system to provide a discharge path from the charged particles. For nonconducting or hard to ground articles, a precharge section places on the articles an initial charge of opposite polarity from the charged particles. A powder feed using a cylinder and piston arrangement to contain fluidized powder supplies a uniform powder suspension to the guns.[US3991710A]
Patent IE-881153-L (IE)
Title: Producing hard abrasive particles
IPC: C01B31/06
Filed: 1988-04-15
Abstract: Friable abrasive particles, particularly diamond particles, are produced by causing suitable material, such as a chloride salt, to be occluded in the particles during their manufacture and then removing some of this material, for example, by leaching.
[EP0289224A1]
Patent IE-45863-L (IE)
Title: Prostanoic acids.
IPC: A61K31/215
Filed: 1977-08-03
Abstract: Prostanoic acid derivatives of the formula <IMAGE> wherein R1 is an acid, ester, amide or hydroxyalkylene group; R2 and R3 are H or alkyl; R4 and R5 are both CH3 or one is Cl and the other is CH3; A is CH2CH2 or -CH=CH; B is CH2CH2, trans-CH=CH, -C 3BOND C-or <IMAGE> W is free or functionally modified hydroxyalkylene or carbonyl; Z is free or functionally modified hydroxymethylene or carbonyl; X Y is either <IMAGE> or, when Z is free or functionally modified hydroxymethylene, <IMAGE> or, when Z is free or functionally modified carbonyl, -CH=CH-, R12 being H, CH3, CN or free or functionally modified hydroxy; and physiologically acceptable salts thereof when R1 is an acid group, possess pharmacological activity, including abortion triggering activity.
[US4284646A]
Patent IE-37049-L (IE)
Title: Preservation of foodstuffs
IPC: B65B25/00
Filed: 1972-12-29
Abstract: 1408015 Preservation ETABS GATINEAU SA 21 Dec 1972 [29 Dec 1971 31 Oot 1972] 59131/72 Heading A2D A method of improving the preservation of foodstuffs contained in flexible plastics packages, in which they are enclosed under vacuum and in which they have been subjected to a sterilizing heat-treatment, comprises, subsequent to the heat-treatment, causing a controlled amount of carbon dioxide to migrate through the wall of the flexible plastic package. The migration or carbonation may be carried out by placing the package in a large volume of carbon dioxide for a controlledtime period. Alternatively, carbonation may be achieved by placing the package in a small gas-impervious enclosure which contains a mixture of carbon dioxide and another gas such as nitrogen, and carbonation is controlled by varying the carbon dioxide content of the gas mixture. A further means of carbonation comprises subjecting the package to jets of carbon dioxide issuing from appropriate nozzles. The method may be carried out in the apparatus shown in Fig. 1, wherein foodstuffs e.g. potatoes are fed from bunker 11 to packaging station 12 where the foodstuffs are vacuum-packed in flexible packages 13. The resultant packages E are then passed to a sterilizing treatment station 15. After sterilization, the packages, optionally before complete cooling, are subjected to carbonation in station 16. This station is a large-volume enclosure filled with carbondioxide, and means 20 control the time during which the packages are subjected to the carbon dioxide.
[GB1408015A]
Patent IE-39034-L (IE)
Title: Cyclopropane derivatives
IPC: C07C51/00
Filed: 1973-11-09
Abstract: 1420636 cyclopropane derivatives ROUSSEL UCLAF 9 Nov 1973 [10 Nov 1972] 52169/73 Heading C2C The invention comprises stereoisomers of compounds of the formula wherein the olefinic double bond is of E-structure and X represents an alkyl group containing from 1 to 6 carbon atoms (optionally substituted by a halogen atom, or by an alkoxy group); a benzyl group (optionally substituted by one or more substituents selected from alkyl, alkenyl, alkadienyl, methylenedioxy and benzyl groups, and halogen atoms); a cyclohexenedicarboximido-methyl group having the olefinic double bond at any position in the carbocyclic ring and optionally substituted on the ring by one or more halogen atoms, methyl groups or acetoxy groups; a group of formula wherein Y 1 and Y 2 , which may be the same or different, each represents a hydrogen atom, an alkyl, alkenyl or alkadienyl group and Y 3 represents a hydrogen atom, or an optionally substituted alkyl, alkenyl, alkadienyl, aryl or heterocyclic group; or a group of formula wherein Z represents an alkyl, alkenyl, alkynyl, aryl, aralkyl, cycloalkyl, cycloalkenyl or heterocyclic group; and Y represents an alkyl group containing from 1 to 6 carbon atoms. The invention further comprises stereoisomers of compounds of the formulae The compounds of Formula I may be obtained by reducing a compound of the formula to give a compound of Formula III, reacting this with a strong base and an esterifying and etherifying agent and if desired saponifying the ester function to give a compound of Formula IV<SP>1</SP> and subsequently converting this into the desired ester.
[GB1420636A]
Patent IE-792246-L (IE)
Title: Composite materials
IPC: D21H13/14
Filed: 1979-11-23
Abstract: In a process for the manufacture of composite material comprising a matrix of set inorganic binder (e.g. Portland cement) and reinforcing fibre (e.g. carbon fibre), by de-watering a slurry containing water-settable inorganic binder, reinforcing fibre and web-forming fibre (e.g. cellulose fibre), and subsequently setting the binder, a ball clay is included in the slurry that is de-watered, in order to reduce shrinkage of the composite material during setting of the binder.
[US4279695A]
Patent IE-802388-L (IE)
Title: Hydraulic binders.
IPC: C04B14/30
Filed: 1980-11-17
Abstract: A hydraulic binder is obtained by mixing Portland cement clinker with hydrated alumina in such proportions that the Ca(OH)2 formed during the hydration of the Portland cement clinker combines completely with the alumina as it is formed.
[GB2063240A]
Patent IE-812426-L (IE)
Title: Tyre breaker cord fabric
IPC: D04H3/05
Filed: 1981-10-15
Abstract: An apparatus and method of manufacture for making tire breaker cord fabric comprising a tire cord laying head to lay a zig-zag assembly of a single cord, edge loop holding units and drive means for relatively moving the cord assembly to an elastomeric material coating device.
[US4401493A]
Patent IE-792474-L (IE)
Title: Switching device
IPC: H01L21/762
Filed: 1979-12-19
Abstract: A high voltage solide-state switch, which allows alternating current or direct current operation and provides bidirectional blocking, consists of a first p-type semiconductor body (16) separated from a semiconductor substrate (12) by a dielectric layer (14) with a p+ type anode region (18), an n+ type cathode region (24) and an n+ type gate region (20) located on a common major surface of the semiconductor body. A second p type region (22) of higher impurity concentration than the semiconductor body encircles the cathode region. Separate low resistance electrical contacts are made to the anode, cathode, and gate regions.
[GB2049283A]
Patent IE-882660-L (IE)
Title: New yeast strains providing for an enhanced rate of the fermentation of sugars, a process to obtain such yeasts and the use of these yeasts
IPC: C12N15/81
Filed: 1988-09-02
Abstract: New yeast strains providing for an enhanced rate of the fermentation of sugars, and a process to obtain such yeasts and the use of these yeasts. Yeasts capable of improved fermentation of sugars, a process to obtain these yeasts and the use of these yeasts are provided. The yeasts show higher rates of metabolism resulting in for example higher carbon dioxide and ethanol production in media containing sugars, such as maltose, as main carbon and energy source. The fermentation rate of sugars is improved by the introduction into a yeast of one or more DNA constructs comprising at least one gene encoding a protein promoting the uptake and/or initial metabolic conversion of a transported sugar substrate.
Patent IE-42764-L (IE)
Title: Curable composition comprising a dissolved polymer
IPC: C09J4/02
Filed: 1975-12-30
Abstract: Curable compositions based on acrylate-type monomers in combination with free radical initiators, the cure of which is inhibited by contact with oxygen are rendered nontacky by inclusion of a compatible organic solvent in which has been dissolved an organic polymeric substance having an average molecular weight of at least about 10,000 and a glass transition temperature of at least about 0?. Upon evaporation of the solvent, the polymeric substance forms a film on the uncured surface of the composition, rendering the surface dry to the touch and substantially limiting oxygen transmission to the uncured composition, thereby enhancing cure. The compositions are useful as coatings or adhesives.
[CA1093726A]